Hepatic Impairment Just after oral administration of just one four mg dose (two mg hydromorphone immediate-release tablets), mean exposure to hydromorphone (Cmax and AUC∞) is elevated four-fold in individuals with reasonable (Youngster-Pugh Team B) hepatic impairment when compared with subject